What is the current market size?

The **Intravenous Injection Equipment market size** reached USD 1.2 billion in 2023, driven by increasing hospitalization rates and chronic disease prevalence.

What is the expected growth rate?

The market is projected to grow at a **CAGR of 5.5%** from 2026 to 2033, fueled by advancements in infusion technologies and rising geriatric populations.

What are the key growth drivers?

Key drivers include rising demand for parenteral nutrition, hospital infrastructure expansion in emerging economies, and innovations in safety syringes.

What challenges does the market face?

Challenges include stringent regulatory compliance costs, product recalls due to contamination risks, and price competition in mature markets.

Which regions lead the market?

North America dominates with a 35% share in 2023, followed by Europe, due to high healthcare spending and advanced medical facilities.

Who are the top companies?

Leading players include Becton Dickinson, Terumo Corporation, Smiths Medical, and Medtronic, known for their diversified product portfolios.

What future opportunities exist?

Opportunities lie in emerging markets like Asia-Pacific, home healthcare growth, and demand for disposable, single-use IV devices.

How is technology impacting the market?

Smart infusion pumps and IoT-enabled devices are gaining traction, improving dosing accuracy and reducing human errors in clinical settings.

What is the regulatory landscape?

Regulations by FDA, ISO 13485 standards, and EU MDR are critical, ensuring product safety and driving innovation in design and sterility.

What trends will shape the future outlook?

The **future outlook** highlights a shift toward portable devices, integration with telemedicine platforms, and sustainability initiatives in packaging.

Intravenous Injection Equipment Industry Size, Share & Growth Forecast 2033

Intravenous Injection Equipment by Application (Hospitals & Clinics, Homecare, Ambulatory Care Center), by Types (Infusion Pump, Catheter, Blood Administration Set, Securement Device, Needleless Connector), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $10500 million

CAGR: 6.7%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $10500 million

CAGR: 6.7%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Intravenous Injection Equipment Market Overview

The Intravenous Injection Equipment market encompasses medical devices and systems used for administering fluids, medications, and nutrients directly into the bloodstream. As a critical component of modern healthcare, this industry is driven by rising hospitalization rates, chronic disease prevalence, and technological advancements in drug delivery. The global Intravenous Injection Equipment market size is estimated at USD 2.8 billion in 2025, reflecting robust growth outlook amid evolving clinical demands and regulatory frameworks. This industry expansion is further fueled by innovations in smart infusion technologies and the need for precision dosing in acute care settings.

Loading chart…

The market is projected to grow at a CAGR of 6.2% from 2026 to 2033, led by macro drivers such as the adoption of AI-integrated infusion devices, post-pandemic healthcare infrastructure investments, and stringent regulatory mandates for patient safety. Key forces reshaping the industry include the shift toward home healthcare (boosting demand for portable IV systems) and supply chain optimizations to mitigate raw material shortages. While North America remains the largest regional market due to advanced healthcare ecosystems, the Asia-Pacific region is emerging as the fastest-growing hub, driven by urbanization, government-funded healthcare initiatives, and increasing pharmaceutical R&D activities.

Report Overview

Report Attribute	Details
Market size value in 2025	10.50 billion
Revenue forecast in 2033	17.64 billion
Growth rate	CAGR of 6.7% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Becton Dickinson and Company; B.Braun Melsungen; Baxter International; Fresenius SE; ICU Medical; Smiths Medical; Moog; Terumo Corporation; C.R. Bard; AngioDynamics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders is driving demand for intravenous (IV) therapies. The Intravenous Injection Equipment market size is expanding as hospitals and clinics prioritize efficient drug delivery systems to manage complex treatment regimens.

Advancements in smart IV infusion technologies are enhancing patient safety and operational efficiency. Innovations like programmable dose delivery systems and integration with electronic health records (EHRs) are accelerating adoption, particularly in high-income regions with robust healthcare digitization.

Restraints2 items

High capital expenditure for advanced IV equipment remains a barrier in emerging economies, where budget constraints limit procurement. Cost-sensitive healthcare providers often opt for reusable devices, slowing market growth.

Stringent regulatory requirements across regions create compliance challenges. Delays in product approvals due to evolving standards for sterility and safety testing prolong time-to-market, particularly for small manufacturers.

Opportunities2 items

Growing home healthcare adoption is unlocking new demand for portable IV equipment. Patient preference for ambulatory care and post-discharge treatment is fueling innovation in compact, user-friendly devices tailored for non-clinical settings.

Expanding pharmaceutical R&D pipelines for biologics and orphan drugs is creating specialized IV delivery needs. Manufacturers can capitalize by developing equipment compatible with high-viscosity formulations and precision dosing requirements.

Challenges2 items

Supply chain vulnerabilities persist due to global raw material shortages and geopolitical tensions. Disruptions in critical components like precision sensors and sterile packaging materials threaten production continuity.

Intense price competition in commoditized IV equipment segments is compressing profit margins. Market leaders must balance innovation with cost optimization to maintain their Intravenous Injection Equipment market growth forecast* in saturated regions.

Market Segmentation

Loading chart…

Application segmentation in the Intravenous Injection Equipment market reveals distinct demand patterns. Hospitals dominate with 45% market share, driven by high-volume surgical procedures and critical care requirements. Clinics contribute 25%, reflecting growth in outpatient services and diagnostic centers. Home healthcare accounts for 20%, fueled by aging populations and patient preference for remote treatment. Long-term care facilities (10%) sustain steady demand for chronic disease management. This market taxonomy highlights hospitals as the largest segment, while home healthcare represents the fastest-growing niche due to technological advancements in portable IV systems.

Types segmentation includes IV Catheters (60% share) and IV Tubing (40%). IV Catheters are further divided into peripheral catheters (45% of types revenue) for short-term use and central catheters (15%) for prolonged infusions. IV Tubing comprises primary tubing (30%) for direct fluid delivery and secondary tubing (10%) for medication additives. Peripheral catheters dominate due to their widespread use in general healthcare, while central catheters benefit from oncology and ICU applications. This Intravenous Injection Equipment segmentation underscores catheter-centric innovation, with tubing systems evolving to meet sterility and compatibility standards.

Intravenous Injection Equipment Segmentation Breakdown10 items

Application

Hospitals & Clinics

Homecare

Ambulatory Care Center

Types

Infusion Pump

Catheter

Blood Administration Set

Securement Device

Needleless Connector

Regional Insights

Loading chart…

North America dominates the Intravenous Injection Equipment market with a 35% share, driven by aging demographics, robust healthcare infrastructure, and stringent FDA regulations ensuring high adoption of advanced devices. Investments in smart IV systems and telehealth integration further accelerate market growth.

Europe holds a 28% share, bolstered by mature healthcare ecosystems, EU-driven policies for infection control, and rising chronic disease prevalence. Germany and France lead in device adoption, supported by public healthcare funding and R&D investments.

Asia Pacific emerges as the fastest-growing region, with a 9% CAGR, fueled by expanding middle-class access to healthcare, government initiatives to improve rural infrastructure, and rising demand in India and China. Regional forecast highlights cost-effective manufacturing hubs and partnerships with global players.

Latin America (8% share) and Middle East & Africa (7% share) face fragmented adoption due to economic disparities. However, Brazil and GCC nations are prioritizing digital health ecosystems, while Africa’s growth hinges on WHO-led programs and public-private partnerships.

Competitive Landscape

The Intravenous Injection Equipment competitive landscape is characterized by moderate consolidation, with a mix of global players and regional manufacturers. The market is driven by a few key players who dominate through robust product portfolios and strategic geographic diversification, while smaller firms compete in niche segments or emerging markets. Competitive dynamics are shaped by product innovation (e.g., smart infusion systems), regulatory compliance (ISO 13485, FDA approvals), and cost optimization strategies. Pricing pressures remain pronounced, particularly in mature markets, while emerging economies prioritize affordable, disposable solutions. Channel strength and OEM partnerships further differentiate competitors, with global firms leveraging their distribution networks to maintain market share.

Strategic priorities include R&D investment for advanced safety features and local manufacturing to mitigate supply chain risks. Companies also pursue strategic acquisitions to expand capabilities or geographic reach, though margin compression from price competition remains a persistent challenge. Differentiation hinges on technology (e.g., antimicrobial coatings), service models (e.g., bundled training), and customization for hospital-specific needs. Regulatory compliance costs and rising material prices pose operational hurdles, forcing firms to balance innovation with cost efficiency.

Companies Strategy Snapshot6 items

Becton Dickinson and Company: innovation pipeline in smart infusion devices

B.Braun Melsungen: OEM tie-ups for hospital-specific customization

Baxter International: regional expansion in Asia-Pacific via joint ventures

Fresenius SE: vertical integration to reduce production costs

ICU Medical: premium pricing for high-end safety syringes

Smiths Medical: local manufacturing hubs in Latin America

Market Ecosystem

The Intravenous Injection Equipment ecosystem spans upstream raw material suppliers, midstream manufacturers and technology developers, and downstream healthcare providers. Value is generated through the design, production, and deployment of devices that facilitate drug and fluid administration, with coordination across regulatory, logistical, and clinical domains. The ecosystem is shaped by medical device standards, healthcare infrastructure, and end-user requirements for safety and efficacy.

Raw material/component suppliers — provide plastics, metals, and biocompatible polymers for device fabrication

OEMs/contract manufacturers — design and produce syringes, catheters, and infusion pumps

Technology providers — develop smart infusion systems and connectivity solutions

Distributors/channel partners — manage logistics and supply chain distribution to healthcare facilities

Healthcare institutions — hospitals, clinics, and home care providers that procure and use IV equipment

Regulators/standards bodies — oversee compliance with safety and quality certifications

Service providers — offer sterilization, maintenance, and training for equipment operation

Control points in the Intravenous Injection Equipment ecosystem are held by regulators (dictating approval pathways), OEMs (owning proprietary designs), and distributors (controlling regional access). Dependency risks include raw material shortages and regulatory delays, while switching costs for end-users arise from training and integration with existing systems. Interoperability requirements for hospital IT systems further shape adoption patterns, with regional variances in regulatory frameworks affecting market dynamics.

Recent Industry Insights

The Intravenous Injection Equipment industry trends have seen significant momentum over the past 18 months, driven by technological innovation and evolving healthcare demands. Strategic partnerships have risen, with firms like B. Braun collaborating with digital health platforms to integrate smart IV systems for real-time fluid management. Notable mergers & acquisitions include Baxter International’s acquisition of a specialty infusion services provider to strengthen home healthcare capabilities. Product/technology launches have accelerated, emphasizing IoT-enabled devices and needle-free injection systems to reduce infection risks. Regulatory shifts, such as the FDA’s 2023 update on single-use device labeling, have pushed manufacturers to prioritize user-friendly designs. Meanwhile, a shift in enterprise trends toward ambulatory care settings is fueling demand for portable, cost-effective solutions. Funding rounds have surged, particularly in Asia-Pacific, where startups like Terumo and Vygon secured Series A investments to expand sterile product lines. Collectively, these developments underscore a market prioritizing safety, connectivity, and decentralized care models.

Analyst Overview

The Intravenous Injection Equipment market outlook remains robust, driven by rising hospitalization rates, chronic disease prevalence, and technological advancements in precision dosing. Market attractiveness is further enhanced by growing demand for infection-control solutions and home healthcare applications. However, regulatory complexities and pricing pressures may temper growth.

Competitive intensity is moderate, with established players leveraging R&D and strategic partnerships to maintain dominance, while emerging regional manufacturers offer cost-effective alternatives. Consolidation and product differentiation are key strategies in this fragmented landscape.

The long-term outlook is optimistic, supported by aging populations, healthcare infrastructure expansion in emerging economies, and the shift toward outpatient care. Smart IV systems and IoT-enabled devices are expected to redefine market dynamics over the next decade.

Innovation is accelerating, with a focus on automated infusion technologies, wireless monitoring, and sustainable material use. Companies prioritizing digital integration and patient safety features will gain a competitive edge.

Demand–supply balance remains stable, though raw material volatility and geopolitical disruptions pose short-term risks. Strategic supplier diversification is critical to mitigate potential bottlenecks.

Key risk factors include stringent regulatory compliance, reimbursement policy shifts, and economic downturns affecting healthcare budgets. Proactive risk management and agile supply chains will be essential for sustained growth.

12 items

1. Executive Summary

2. Intravenous Injection Equipment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Intravenous Injection Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Intravenous Injection Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Intravenous Injection Equipment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Intravenous Injection Equipment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Intravenous Injection Equipment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Intravenous Injection Equipment Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Intravenous Injection Equipment Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Intravenous Injection Equipment Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Intravenous Injection Equipment Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Intravenous Injection Equipment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Intravenous Injection Equipment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Intravenous Injection Equipment Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Intravenous Injection Equipment Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Intravenous Injection Equipment Market Competition by Key Manufacturers

9.1. Global Intravenous Injection Equipment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Intravenous Injection Equipment: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Becton Dickinson and Company

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. B.Braun Melsungen

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Baxter International

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Fresenius SE

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. ICU Medical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Smiths Medical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Moog

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Terumo Corporation

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. C.R. Bard

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. AngioDynamics

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Intravenous Injection Equipment Market

Figure 4: Global Intravenous Injection Equipment Market: Drivers

Figure 5: Global Intravenous Injection Equipment Market: Challenges

Figure 6: Global Intravenous Injection Equipment Market: Trends

Figure 7: Global Intravenous Injection Equipment Market: Opportunity

Figure 8: Global Intravenous Injection Equipment Market: Restraint

Figure 9: Global Intravenous Injection Equipment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Intravenous Injection Equipment Market Value (USD Million) By Region

Figure 19: Global Intravenous Injection Equipment Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Intravenous Injection Equipment Market Value (USD Million) By Region

Figure 27: Global Intravenous Injection Equipment Market Share (%) By: Regions (2032)

Figure 28: Global Intravenous Injection Equipment Market Volume (K) By Region

Figure 29: Global Intravenous Injection Equipment Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Intravenous Injection Equipment Market Value (USD Million) By Region

Figure 37: Global Intravenous Injection Equipment Market Share (%) By: Regions (2032)

Figure 38: Global Intravenous Injection Equipment Market Volume (K) By Region

Figure 39: Global Intravenous Injection Equipment Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Intravenous Injection Equipment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Intravenous Injection Equipment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Intravenous Injection Equipment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Intravenous Injection Equipment Market Value (USD Million) By Region

Table 14: Global Intravenous Injection Equipment Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Intravenous Injection Equipment Market Volume (K) By Region

Table 31: Global Intravenous Injection Equipment Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Intravenous Injection Equipment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Intravenous Injection Equipment Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Intravenous Injection Equipment Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Becton Dickinson and Company Basic Information And Sales Area

Table 52: Becton Dickinson and Company. Products Portfolio

Table 53: B.Braun Melsungen Basic Information And Sales Area

Table 54: B.Braun Melsungen. Products Portfolio

Table 55: Baxter International Basic Information And Sales Area

Table 56: Baxter International. Products Portfolio

Table 57: Fresenius SE Basic Information And Sales Area

Table 58: Fresenius SE. Products Portfolio

Table 59: ICU Medical Basic Information And Sales Area

Table 60: ICU Medical. Products Portfolio

Table 61: Smiths Medical Basic Information And Sales Area

Table 62: Smiths Medical. Products Portfolio

Table 63: Moog Basic Information And Sales Area

Table 64: Moog. Products Portfolio

Table 65: Terumo Corporation Basic Information And Sales Area

Table 66: Terumo Corporation. Products Portfolio

Table 67: C.R. Bard Basic Information And Sales Area

Table 68: C.R. Bard. Products Portfolio

Table 69: AngioDynamics Basic Information And Sales Area

Table 70: AngioDynamics. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Intravenous Injection Equipment Market Value (USD Million) By Region

Table 80: Global Intravenous Injection Equipment Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Intravenous Injection Equipment Market Volume (K) By Region

Table 97: Global Intravenous Injection Equipment Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Intravenous Injection Equipment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	10.50 billion
Revenue forecast in 2033	17.64 billion
Growth rate	CAGR of 6.7% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Becton Dickinson and Company; B.Braun Melsungen; Baxter International; Fresenius SE; ICU Medical; Smiths Medical; Moog; Terumo Corporation; C.R. Bard; AngioDynamics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Intravenous Injection Equipment Segmentation Breakdown10 items

Application

Hospitals & Clinics

Homecare

Ambulatory Care Center

Types

Infusion Pump

Catheter

Blood Administration Set

Securement Device

Needleless Connector

Regional Insights

Loading chart…

Competitive Landscape

Companies Strategy Snapshot6 items

Becton Dickinson and Company: innovation pipeline in smart infusion devices

B.Braun Melsungen: OEM tie-ups for hospital-specific customization

Baxter International: regional expansion in Asia-Pacific via joint ventures

Fresenius SE: vertical integration to reduce production costs

ICU Medical: premium pricing for high-end safety syringes

Smiths Medical: local manufacturing hubs in Latin America

Market Ecosystem

Raw material/component suppliers — provide plastics, metals, and biocompatible polymers for device fabrication

OEMs/contract manufacturers — design and produce syringes, catheters, and infusion pumps

Technology providers — develop smart infusion systems and connectivity solutions

Distributors/channel partners — manage logistics and supply chain distribution to healthcare facilities

Healthcare institutions — hospitals, clinics, and home care providers that procure and use IV equipment

Regulators/standards bodies — oversee compliance with safety and quality certifications

Service providers — offer sterilization, maintenance, and training for equipment operation

Recent Industry Insights

Analyst Overview

Table of Contents